enCELL Master stands as a testament to research empowerment
This versatile microfluidic platform serves as a cornerstone for researchers, offering precise control over particle generation for a multitude of applications. From nanoparticle synthesis to bioprocessing, enCELL Master revolutionizes experimentation.
- Activation of mRNA research / Expansion of the market by securing mass production
- Reinforcing awareness through presentations at conferences and participation in exhibitions
- Secure reference sites such as KIST and Seoul National University Cancer Center
- 50~60% price supply compared to PNI (equipment, consumables)
- Launched in September 22, 12 units delivered and additional sales in progress
- No.1 in Korea by 2025
- PNI’s oligopolistic promotion of overseas market entry
- Oxford University hospital equipment installation and test bed utilization agreement
- Oxford University international cooperation MOU signed and PR strengthened through journals
- European/UK distribution through Geneflow and Quantoom (CE certification)
- US/Japan (Wase-Gen Collaboration) Securing distribution network (within 23 years)
- Full-scale participation in exhibitions (CPHI, BIO USA, etc.)
- Sales target of 30 or more units per year
Partner with Us for Microfluidics Excellence
Contact us today to explore how our microfluidics solutions can empower your pharmaceutical endeavors. Let’s shape the future of medicine together.
EnCell is trying to develop a clear and comprehensive sustainability strategy.
This strategy should outline the company's commitment to environmental stewardship, social responsibility, and economic viability. Our company's efforts, setting priorities, and driving continuous improvement towards a more sustainable microfluidics solution company.